323 people have bought this recently
Carca 6.25 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of High BP. The alternative uses of Carca 6.25 Tablet (15) have also been explained below.
The right dosage of Carca 6.25 Tablet (15) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Carca 6.25 Tablet (15) as well, which are listed below. Usually, these side effects of Carca 6.25 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Carca 6.25 Tablet (15)'s effect is Moderate during pregnancy and Safe for lactating mothers. Warnings related to Carca 6.25 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Carca 6.25 Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Carca 6.25 Tablet (15) in conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD). The section on Carca 6.25 Tablet (15) contraindications lists all such conditions.
Drug interactions for Carca 6.25 Tablet (15) have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Carca 6.25 Tablet (15) is considered not safe while driving, and is not addictive.
Carca 6.25 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Carca 6.25 Tablet (15) safe for pregnant women?
Pregnant women may experience moderate side effects from Carca. It is best to stop taking Carca immediately and inform your doctor if you notice any discomfort.
Is the use of Carca 6.25 Tablet (15) safe during breastfeeding?
Carca does not show any side effects in breastfeeding women.
What is the effect of Carca 6.25 Tablet (15) on the Kidneys?
Carca is not harmful for kidneys.
What is the effect of Carca 6.25 Tablet (15) on the Liver?
Carca is rarely harmful for the liver.
What is the effect of Carca 6.25 Tablet (15) on the Heart?
Carca may have mild side effects on the heart. Most people will never see any effect on the heart.
Carca 6.25 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carca 6.25 Tablet (15) unless your doctor advises you to do so -
Is this Carca 6.25 Tablet (15) habit forming or addictive?
Carca 6.25 Tablet (15) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Carca 6.25 Tablet (15) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Carca 6.25 Tablet (15) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Carca 6.25 Tablet (15) is not used to treat mental disorders.
Interaction between Food and Carca 6.25 Tablet (15)
Eating certain foods may increase the time it takes Carca 6.25 Tablet (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carca 6.25 Tablet (15)
Consumption of alcohol and Carca 6.25 Tablet (15) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)
Download App
